Concourse Financial Group Securities, Inc. M Dx Health Sa Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023
BUY
$2.69 - $3.86 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023
BUY
$2.69 - $3.86 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023
BUY
$3.07 - $4.2 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$2.61 - $7.15 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$6.2 - $8.36 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$6.1 - $8.84 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$6.65 - $9.33 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$7.69 - $10.27 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$8.45 - $12.0 $0 - $0
0 New
0 $0

Others Institutions Holding MDXH

# of Institutions
1
Shares Held
9.5K
Call Options Held
0
Put Options Held
0
View Full List

About MDxHealth SA

MDXH Quotes by TradingView
  • Ticker MDXH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,288,100
  • Market Cap $31.6M
  • Description
  • MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which prov...
More about MDXH
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email